DNAP test results:

http://www.kerchner.com/dnaprint25vs20.htm

Oh well, is late

Ann

This page mentions DNAP test:

http://www.kerchner.com/bga-proj.htm

Ann

Thank you, ride:

Here's more:

http://www.aafs.org/default.asp?section_id=aafs&page_id=about_us

Ann

This might be a good thing for our "newbies" doing DD to read:

http://www.biobn.com/index.cfm?Page=viewnews&NewsID=0001875731

Ann

And the same to you, Work.

Ann

Work - just 4 your info, here's the page from DNAP website:

http://www.dnaprint.com/2003/Corporate/aboutus.html

Take care

Ann

From DNAP site:

We are currently focusing our efforts in four distinct markets:

Pharmacogenomics Market - The testing of individuals to predict their genetic predisposition to drug response is known as pharmacogenomics. Pharmacogenomics enables physicians to tailor drug therapies (formulation and dosage) for individuals based on their genetic composition, increasing rates of therapeutic success and decreasing rates of adverse side effects. Drug discovery companies are beginning to use pharmacogenomics technologies to develop drugs that are suitable for subpopulations based upon their genetic composition.

Forensics DNA Testing Market - Testing DNA to create a physical profile of crime suspects is a new market based on evolving technologies. Common hereditary traits such as skin pigmentation, eye color, hair color, earlobe attachment and height can be predicted through analysis of DNA sequences. DNAPrintTM believes it is the first company to use DNA evidence to successfully profile a crime suspect by predicting that suspect’s continental origin.

Consumer DNA Products Market - There is an established market of consumers who recreationally research their genealogy and ancestral origin. Additionally, there is a market for paternity tests and other tests related to lineage. DNAPrintTM serves both of these consumer market segments through direct sales and independent distributors.

Ann

Retro:

You have a nice evening.

Ann

retro:

Here's a UK Search Engine 4 u.

http://www.bbc.co.uk/search/whysearch.shtml


Ann

Ok, Bag:

You're saying "sorry."

Ann

Actually, Bag - it's "pazhalsta" - nee zha sto - means - no way - by no means - not in any way. (not sure what the last word you wrote is supposed mean).

Ann

No way, Bag

Ann

Hey, Bag:

I speak, read and write Russian. Couldn't resist telling you that. It is a very difficult language and the Russian vocabulary is 5 times greater than the English language.

Ann

Thanks, Cosmic...we are padding ourselves w/excellent choices.

Ann

Bag:

We are in "excellent" hands! - IMO

Ann

http://www.hoovers.com/free/co/factsheet.xhtml?COID=47090

Ann

"Gray Cary is a national law firm that represents private and public businesses, from growth companies to Fortune 500 corporations, with an emphasis on the technology and life sciences industries. The firm has approximately 400 attorneys practicing in Austin, East Palo Alto, Sacramento, San Diego, San Francisco, Seattle and Washington, D.C."

Ann

DNAP will be well defended:

http://www.legalthoughtleader.com/v2e4/casestudy.htm

Ann

Here's when the merger happened:

http://www.technologylaw.com/

Ann

Slop:

Ya remind me of Yosemite Sam...Daffy Duck...the Road Runner?

But, it's ok...we read 'ya! - lol

Ann

The Town of Sleepy Hollow!
Zzzz to u 2, Team - until then.

Ann

Insider Form 144 holders:

http://finance.yahoo.com/q/ir?s=DNAP.OB

Ann

Posting to keep you from all napping too much - lol

FYI:

http://www.dnaprint.com/2003/corporate/conferences.html

Ann

Anyone interested in getting a copy and sharing?

(write-up from Amsterdam Conf.)
"During the presentation, DNAPrint also announced that some of the early work on human iris color has been accepted for publication in the peer-reviewed journal "Genetics." The paper "Sequences Associated with Human Iris Pigmentation" will appear in the upcoming December issue."

Ann

Dmceng = results & revenue = to da mooooooon!

Ann

Though this is DNAP's attendance at Amsterdam Convention, dated 11/03 - I don't recall seeing this particular article:

http://www.forensicfocusmag.com/hotnews/3bh2573837.html

Ann

I guess we've established that DNAP's moving or in transition?
If you scroll down to DNAP in this Pharmaceutical Directory, DNAP doesn't list a current address like they used/none at all:

http://www.informagen.com/Addresses/D.php

Ann

Posted wrong - sorry

Found in search engine for DNAPrint:

http://www.dnaprint.com/pr_06_05_03.htm

Ann

Whoops! "Slopster" (will write it a 100 times on my blackboard) - Ann

Slipster:

No OT: This is NOT the weekend and you're only allowed to talk DD.

Ann

Wonder what's up? Some of my search engines/& collosal engines aren't submitting DNAPrint information posts, as previously.

Hmm...Ann

Darn, Quadro:

You woke me - zzzzzzzzzzzzzzzzzzzzzz! - lol

Ann

Line-up: (Speakers/dates & times):

http://www.aafs.org/pdf/calevent.pdf

Ann

AAFS:

http://www.aafs.org/default.asp?section_id=meetings&page_id=aafs_annual_meeting

Ann

Scroll down to DNAPRINT. They used to list the Sarasota address. No current address information published at this time.

Ann

FDA Guidelines for Pharmacogenomic submissions:

http://www.fda.gov/cder/guidance/5900dft.pdf

Ann

To All:

Received this e-mail today.

Press Release





Dr. Shaharuddin Datuk Aziz to Become DNA Phenomics' Chief Scientific Officer


Noted Malaysian Biochemist to Direct Company's Genomic Research Program

KUALA LUMPUR, Malaysia – February 19, 2004 – DNA Phenomics Sdn Bhd, a development-stage company focused on the emerging field of phenomics and the development of genomic-based diagnostic tests and drug discovery, announces that Dr. Shaharuddin Datuk Aziz, a noted biochemist and emeritus member of the Medical Faculty of Universiti Kebangsaan Malaysia, will become DNA Phenomics' Chief Scientific Officer (CSO), leading the company's nascent genomics research program and phenomics discovery efforts.

"A series of events provided us with the unexpected opportunity of being able to offer the CSO position to Dr. Shaharuddin. Fortunately for the company, he accepted and has agreed to begin immediately leading our genomic research program," said Mr. Ezehan Kamaluddin, DNA Phenomics' Chief Operating Officer. "There were a number of outstanding candidates here and abroad we considered for this position. Dr. Shaharuddin has over 30 years of experience in biochemistry and biotechnology. He knows the ins and outs of both the university research laboratory as well as the corporate boardroom. The value of his scientific work has been recognized time and again in the form of PETRONAS, UNESCO, and KUOK Foundation awards for research in Recombinant DNA Technology. Dr. Shaharuddin takes a hands-on approach in the lab and will continue that tradition with DNA Phenomics."

Dr Shaharuddin holds several patents and has published numerous journal articles, book chapters and technical reports for local and international organizations on Polymerase Chain Reaction techniques, rDNA, cDNA, globin gene mutation in thallasaemias, steroid hormone biochemistry, and molecular Endocrinology. In addition to his position at Universiti Kebangsaan Malaysia, over the years he has served as Visiting Research Scientist in the Department of Biochemistry at Japan's Kyushu University; the National Institute of Radiological Sciences in Chiba, Japan; and the Research Laboratory for Genetic Information in Fukuoka, Japan. He routinely consults for various corporations in the biotechnology sector. In addition to extensive work experience with various universities, research institutes and scientific agencies, Dr. Shaharuddin also advises the investment community, pharmaceutical companies and established and emerging biotech companies. Dr. Shaharuddin's broad knowledge of the biotech market has led business leaders to seek his counsel for market research, competitive intelligence, corporate development, the commercialization of scientific research ideas, strategic planning, and assessment and identification of potential alliance partners.

Dr Shaharuddin Datuk Aziz was trained at the Jinnah Postgraduate Medical Institute, University of Karachi, and at the Institute of Biochemistry, University of Glasgow, Scotland (Ph.D.). He received further postdoctoral training at the Beatson Institute of Cancer Research (Glasgow, Scotland), Pasteur Institute (Paris, France), and the European Molecular Biology Organization Research Lab (Heidelberg, Germany). As a faculty member, most of his career has been with the Biochemistry Department, Medical Faculty of Universiti Kebangsaan Malaysia from 1974 to 2003.


About DNA Phenomics
DNA Phenomics is a development-stage company focused on the emerging field of phenomics and the development of genomic-based diagnostic tests and drug discovery. The company's phenomics discovery platform offers university labs as well as pharmaceutical and life science companies a powerful research tool for uncovering patterns in the genome associated with health factors and drug responses. The company's goal is to become a leader in the discovery, development, and sale of genomic-based diagnostic healthcare products, pharmaceuticals, and biotech research services throughout Asia and the Pacific. Founded in 2003, DNA Phenomics is headquartered in Kuala Lumpur, Malaysia. DNA Phenomics is a privately-held company. Additional information about DNA Phenomics and its genomic-based solutions can be found at www.DNAphenomics.com.


Public Relations Contacts
Corporate Headquarters

Ezehan Reza Kamaluddin
Chief Operating Officer
28-1, Level 1, Jalan 28/70A
Desa Sri Hartamas
50480 Kuala Lumpur, Malaysia
ezehan@dnaphenomics.com





[TOP]


--------------------------------------------------------------------------------
© Copyright 2003 DNA Phenomic. All rights reserved. "Translating the text of DNA into solutions for humankind" and Logo are the trademarks of DNA Phenomic Sdn Bhd.


Privacy Policy / Site Map

Importantly: the marketing exposure is: (quote article)

"The Lynn Peavey Co. reaches more than 17,000 law enforcement agencies across the country."

Ann

Peavey distribution:

http://www.bizjournals.com/tampabay/stories/2004/02/16/daily14.html

Ann